{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:34:31Z","timestamp":1782902071303,"version":"3.54.5"},"reference-count":88,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.semnephrol.2011.09.003","type":"journal-article","created":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T02:51:46Z","timestamp":1321671106000},"page":"483-494","source":"Crossref","is-referenced-by-count":66,"title":["Update in Diuretic Therapy: Clinical Pharmacology"],"prefix":"10.1016","volume":"31","author":[{"given":"D. Craig","family":"Brater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2011.09.003_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ki.1979.120","article-title":"Pharmacodynamic analysis of the furosemide-probenecid interaction in man","volume":"6","author":"Chennavasin","year":"1979","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/clpt.1980.111","article-title":"Renal tubular secretion and effects of furosemide","volume":"27","author":"Odlind","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3565(25)32821-1","article-title":"Renal tubule transport and electrolyte effects of amiloride in the chicken","volume":"219","author":"Besseghir","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0022-3565(25)31376-5","article-title":"Handling of triamterene by the isolated perfused rat kidney","volume":"206","author":"Kau","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib5","series-title":"The in vivo study of drug action","first-page":"253","article-title":"Diuretic pharmacokinetics and pharmacodynamics","author":"Brater","year":"1992"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/clpt.1981.189","article-title":"Furosemide kinetics in patients with hepatic cirrhosis with ascites","volume":"30","author":"Fuller","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00554663","article-title":"Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide","volume":"20","author":"Keller","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cpt1974152141","article-title":"Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide","volume":"15","author":"Davies","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib9","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/jps.2600730821","article-title":"Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects","volume":"73","author":"Holazo","year":"1984","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/clpt.1993.116","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis","volume":"54","author":"Schwartz","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF00609885","article-title":"Delayed elimination of triamterene and its active metabolite in chronic renal failure","volume":"24","author":"Knauf","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/clpt.1984.121","article-title":"Triamterene kinetics and dynamics in cirrhosis","volume":"35","author":"Villeneuve","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF00544242","article-title":"Pharmacokinetics of amiloride in renal and hepatic disease","volume":"33","author":"Spahn","year":"1987","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/j.1875-9114.1997.tb03681.x","article-title":"Variable furosemide absorption and poor predictability of response in elderly patients","volume":"17","author":"Murray","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/clpt.1994.98","article-title":"The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency","volume":"56","author":"Gehr","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure","volume":"57","author":"Vargo","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9343(01)00903-2","article-title":"Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure","volume":"111","author":"Murray","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00019053-200017050-00002","article-title":"Healthcare costs of patients with heart failure treated with torasemide or furosemide","volume":"17","author":"Stroupe","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib19","first-page":"123","article-title":"Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure","volume":"25","author":"Chaturvedi","year":"1987","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2165\/00003088-199222040-00006","article-title":"Absorption of high dose furosemide (frusemide) in congestive heart failure","volume":"22","author":"Van Meyel","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2165\/00003088-198712060-00004","article-title":"Bioavailability of bumetanide in grossly oedematous patients","volume":"12","author":"Bailie","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ki.1984.153","article-title":"Bumetanide and furosemide in heart failure","volume":"26","author":"Brater","year":"1984","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-102-3-314","article-title":"Furosemide absorption altered in decompensated congestive heart failure","volume":"102","author":"Vasko","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib24","first-page":"450","article-title":"Response of the kidney to furosemide","volume":"102","author":"Wilcox","year":"1983","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0009-9236(97)90069-2","article-title":"Role of duration of diuretic effect in preventing sodium retention","volume":"62","author":"Ferguson","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3565(25)21252-6","article-title":"Acute tolerance to furosemide diuresis in humans","volume":"233","author":"Hammarlund","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0009-9236(96)90170-8","article-title":"Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration","volume":"60","author":"Wakelkamp","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib28","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1681\/ASN.V3121878","article-title":"A volume-independent component to postdiuretic sodium retention in humans","volume":"3","author":"Almeshari","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ki.1983.149","article-title":"Response of the kidney to furosemide","volume":"24","author":"Kelly","year":"1983","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.1987.20","article-title":"Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril","volume":"31","author":"Wilcox","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0773.1992.tb00417.x","article-title":"Renal effects of \u03b1-adrenoceptor blockade during furosemide diuresis in conscious rats","volume":"70","author":"Petersen","year":"1992","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib32","first-page":"F1256","article-title":"Adaptation of distal tubule and collecting duct to increased sodium delivery","volume":"255","author":"Kaissling","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib33","first-page":"F1269","article-title":"Adaptation of distal tubule and collecting duct to increased Na delivery","volume":"255","author":"Stanton","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1172\/JCI113847","article-title":"Adaptation of the distal convoluted tubule of the rat","volume":"83","author":"Ellison","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1989.246","article-title":"Mechanism of impaired natriuretic response to furosemide during prolonged therapy","volume":"36","author":"Loon","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ki.1995.124","article-title":"Tubular hypertrophy due to work load induced by furosemide is associated with increases of IGF-1 and IGFBP-1","volume":"47","author":"Kobayashi","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib37","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib38","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.1987.246","article-title":"Comparison of loop diuretics in patients with chronic renal insufficiency: mechanism of difference in response","volume":"32","author":"Voelker","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00193698","article-title":"Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency","volume":"47","author":"van Olden","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/clpt.1994.99","article-title":"The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency","volume":"56","author":"Rudy","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0002-9343(82)90854-3","article-title":"Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia","volume":"72","author":"Wollam","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ki.1994.298","article-title":"Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure","volume":"46","author":"Fliser","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib43","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00005344-199509000-00008","article-title":"Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure","volume":"26","author":"Knauf","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-115-5-360","article-title":"Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy","volume":"115","author":"Rudy","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/j.1552-4604.1996.tb04197.x","article-title":"Pharmacokinetics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure","volume":"36","author":"Kramer","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0735-1097(96)00161-1","article-title":"Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion","volume":"28","author":"Dormans","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2796.1994.tb01082.x","article-title":"Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance","volume":"235","author":"Van Meyel","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib48","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1378\/chest.102.3.725","article-title":"Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure","volume":"102","author":"Lahav","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ki.1987.192","article-title":"Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients","volume":"32","author":"Inoue","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cpt1978242199","article-title":"Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia","volume":"24","author":"Rane","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib51","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/clpt.1982.187","article-title":"Disposition and diuretic effect of furosemide in the nephrotic syndrome","volume":"32","author":"Keller","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib52","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/clpt.1982.101","article-title":"Furosemide disposition in cirrhosis","volume":"31","author":"Verbeeck","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/clpt.1986.132","article-title":"Furosemide kinetics and dynamics in patients with cirrhosis","volume":"40","author":"Villeneuve","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib54","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1681\/ASN.V1251010","article-title":"Effects of albumin\/furosemide mixtures on responses to furosemide in hypoalbuminemic patients","volume":"12","author":"Chalasani","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0024-3205(80)90238-6","article-title":"Resistance of proteinuric rats to furosemide: urinary drug protein binding as a determinant of drug effect","volume":"26","author":"Green","year":"1980","journal-title":"Life Sci"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib56","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0022-3565(25)32640-6","article-title":"Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion","volume":"218","author":"Green","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib57","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0022-3565(25)20166-5","article-title":"Intratubular albumin blunts the response to furosemide\u2014a mechanism for diuretic resistance in the nephrotic syndrome","volume":"252","author":"Kirchner","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib58","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ki.1991.228","article-title":"Binding inhibitors restore furosemide potency in tubule fluid containing albumin","volume":"40","author":"Kirchner","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib59","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1681\/ASN.V1161100","article-title":"Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome","volume":"11","author":"Agarwal","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib60","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1681\/ASN.V271201","article-title":"Tubular resistance to furosemide contributes to the attenuated diuretic response in nephrotic rats","volume":"2","author":"Kirchner","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000185059","article-title":"Pharmacokinetic and pharmacodynamic interactions between furosemide and hydrochlorothiazide in nephrotic patients","volume":"49","author":"Nakahama","year":"1988","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0002-8703(78)90052-2","article-title":"Spironolactone","volume":"96","author":"Ochs","year":"1978","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib63","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJM197006182822502","article-title":"Compartmentalization of ascites and edema in patients with hepatic cirrhosis","volume":"282","author":"Shear","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib64","first-page":"469","volume":"38","author":"Overdiek","year":"1985","journal-title":"New insights into the pharmacokinetics of spironolactone"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000137299","article-title":"Pharmacokinetics of furosemide in patients with congestive heart failure","volume":"19","author":"Greither","year":"1979","journal-title":"Pharmacology"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00561400","article-title":"Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure","volume":"12","author":"Andreasen","year":"1977","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib67","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/clpt.1980.148","article-title":"Furosemide in patients with heart failure","volume":"28","author":"Brater","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/pgmj.53.617.117","article-title":"The urinary sodium: potassium ratio and response to diuretics in resistant oedema","volume":"53","author":"Alexander","year":"1977","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib69","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","article-title":"Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor","volume":"71","author":"Van Vliet","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib70","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib71","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3565(25)12526-3","article-title":"Carbonic anhydrase inhibition","volume":"123","author":"Maren","year":"1958","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib72","first-page":"113","article-title":"Effects and interactions of furosemide and acetazolamide on tubular function in rat kidney","volume":"33","author":"Rodicio","year":"1977","journal-title":"Rev Esp Fisiol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib73","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/hrt.32.3.399","article-title":"Assessment of proximal tubular sodium reabsorption during water diuresis in patients with heart disease","volume":"32","author":"Gibson","year":"1970","journal-title":"Br Heart J"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib74","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.CIR.42.2.323","article-title":"Influence of sodium balance on the ability of diuretics to inhibit tubular reabsorption","volume":"42","author":"Earley","year":"1970","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib75","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-3565(25)22076-6","article-title":"Pharmacodynamics of the diuretic effects of aminophylline and acetazolamide alone and combined with furosemide in normal subjects","volume":"227","author":"Brater","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-3565(25)26053-0","article-title":"Aminophylline and its relationship to some other diuretic agents in dogs","volume":"132","author":"Nechay","year":"1961","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib77","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0002-8703(77)80276-7","article-title":"The supra-additive natriuretic effect addition of theophylline ethylenediamine and bumetanide in congestive heart failure","volume":"94","author":"Sigurd","year":"1977","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib78","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1681\/ASN.V771032","article-title":"Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure","volume":"7","author":"Vargo","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ki.1996.280","article-title":"Renal-dose dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials","volume":"49","author":"Denton","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9343(96)00075-7","article-title":"Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure?","volume":"101","author":"Chertow","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib81","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2165\/00003495-200161100-00002","article-title":"Renal effects of adenosine A1-receptor antagonists in congestive heart failure","volume":"61","author":"Gottlieb","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib82","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCHEARTFAILURE.108.798389","article-title":"Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure","volume":"2","author":"Mitrovic","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib83","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jacc.2007.03.059","article-title":"Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure","volume":"50","author":"Greenberg","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib84","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cardfail.2008.08.010","article-title":"The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment","volume":"14","author":"Cotter","year":"2008","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib85","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.jacc.2007.07.019","article-title":"The effects of KW-3902, an adenosine A1 receptor antagonist, on dieresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance","volume":"50","author":"Givertz","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib86","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cardfail.2007.08.006","article-title":"The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment","volume":"13","author":"Dittrich","year":"2007","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib87","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","article-title":"BG971 (CVT-124), an adenosine A1 receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2011.09.003_bib88","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951100132X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951100132X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T06:53:28Z","timestamp":1741935208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027092951100132X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S027092951100132X"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2011.09.003","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}